Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research focused on Pulmonary hypertension and Tadalafil, with related work in Ambrisentan, Discontinuation, Cardiology. Notable publications include 'Pulmonary hypertension in chronic lung disease and hypoxia', 'Pulmonary Arterial Hypertension', and 'Pregnancy outcomes in pulmonary arterial hypertension in the modern management era'.
Initial Combination Therapy with Macitentan and Tadalafil in Patients with Pulmonary Arterial Hypertension, with and without Cardiac Comorbidities
Pulmonary hypertension in chronic lung disease and hypoxia
The Right Heart-Pulmonary Circulation Unit
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
Clinical features of pulmonary arterial hypertension in patients receiving dasatinib
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension
Pulmonary Arterial Hypertension
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era